Pan Drugs Ltd. - Research Center
531440 PANDRUG Group (P) BSE data
Results
Statement
More
Mar ' 13 |
Mar ' 12 |
Mar ' 11 |
Mar ' 99 |
Mar ' 98 |
Equity share capital
Share application money
Preference share capital
Reserves & surplus
-11.60 |
-11.32 |
-10.38 |
1.29 |
0.78 |
Secured loans
19.05 |
18.82 |
17.97 |
5.84 |
2.81 |
Unsecured loans
Total
11.20 |
11.24 |
11.24 |
12.61 |
8.75 |
Gross block
12.23 |
10.38 |
9.44 |
4.98 |
4.52 |
Less : revaluation reserve
Less : accumulated depreciation
Net block
Capital work-in-progress
Investments
Current assets, loans & advances
12.94 |
13.72 |
16.04 |
12.18 |
7.91 |
Less : current liabilities & provisions
Total net current assets
Miscellaneous expenses not written
Total
11.20 |
11.24 |
11.24 |
12.61 |
8.75 |
Book value of unquoted investments
Market value of quoted investments
Contingent liabilities
Number of equity sharesoutstanding (Lacs)
50.68 |
50.68 |
31.43 |
50.68 |
50.68 |